Share this page
PR Hub
Breaking News
|
Entertainment
|
Sports
|
Business
|
Politics
|
Science
|
Technology
|
Odd News
|
Health
|
Law
More
Crime Watch
Accidents & Disasters
Religion
Education
Travel
Stem Cell Research
Diabetes
Eye Care
Newsletter
Pet
Press Release
Voice
Microblog
Tokyo And Woburn
Daiichi Sankyo and ArQule Enroll First Non-Small Cell Lung Cancer Patient Into Global Phase III Trial for ARQ 197
TOKYO and WOBURN, Massachusetts, January 12, 2011 - Daiichi Sankyo Company, Limited (TSE 4568) and ArQule, Inc.
MORE..
Older News
S
M
T
W
T
F
S
26
27
28
29
30
31
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
